From Computational Prioritization to Sustainable Supply: A Two-Axis Framework for Marine Invertebrate-Associated Natural Products and Derivatives
Preprint
- 22 September 2026
- preprint
- Published by MDPI AG in Preprints.org
Abstract
Marine invertebrates and their microbial partners provide distinctive chemical scaffolds, but computational prioritization alone can overstate translational progress when experimental support and material supply remain limited. This critical narrative review proposes a linked-record framework for evaluating exact entity-indication pairs on two independent axes: therapeutic-evaluation stage (E1, in silico, to E4, human intervention) and production readiness (S1, discovery access, to S4, GMP or commercial manufacture). E records the highest stage documented in the reviewed sources, not evidence strength or therapeutic success. Computational contribution, evidence direction, study quality, provenance, and scenario-specific supply adequacy remain separate attributes; E and S are not combined into a composite score. Contrasting lineages involving halichondrin B and eribulin, (+)-aeroplysinin-1, a sea-star steroid, acanthomanzamine C, cynthichlorine, gukulenin A, and meridianin mixtures illustrate how uncertain chronology, test-article mismatch, incomplete validation, and poorly characterized production routes affect interpretation. A worked mass balance distinguishes physical access from the amount required for a defined experiment. Supply-by-design therefore integrates identity, route feasibility, demand, ecological constraints, and access obligations at nomination. The framework is preliminary and requires independent reliability and prospective utility testing.Keywords
All Related Versions
- Version 1, 2026-09-22, Preprints
- Published version: Marine Drugs, 24 (11), 394.
This publication has 43 references indexed in Scilit:
- Graph Neural Networks in Modern AI-Aided Drug DiscoveryChemical Reviews, 2025
- Evaluating Machine Learning Models for Molecular Property Prediction: Performance and Robustness on Out-of-Distribution DataJournal of Chemical Information and Modeling, 2025
- Identification of potential Indonesian marine invertebrate bioactive compounds as TMPRSS2 and SARS-CoV-2 Omicron spike protein inhibitors through computational screeningArabian Journal of Chemistry, 2023
- A Deep Learning Approach to Antibiotic DiscoveryCell, 2020
- The Natural Products Atlas: An Open Access Knowledge Base for Microbial Natural Products DiscoveryACS Central Science, 2019
- Analyzing Learned Molecular Representations for Property PredictionJournal of Chemical Information and Modeling, 2019
- Acanthomanzamines A–E with New Manzamine Frameworks from the Marine Sponge Acanthostrongylophora ingensOrganic Letters, 2014
- Lessons from the Past and Charting the Future of Marine Natural Products Drug Discovery and Chemical BiologyChemistry & Biology, 2012
- Eribulin monotherapy versus treatment of physician's choice in patients with metastatic breast cancer (EMBRACE): a phase 3 open-label randomised studyThe Lancet, 2011
- A Critical Assessment of Docking Programs and Scoring FunctionsJournal of Medicinal Chemistry, 2005